Christopher W Szeto (Christopher Szeto)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Locally Advanced

Squamous Cell Carcinoma

Top Venues

Cancer research communications

Clinical cancer research : an official journal of the American Association for Cancer Research

Breast cancer research : BCR

This page only lists publications with an associated author ORCID identifier.

Publications

Peter Andreas Fasching, Christopher W Szeto, Carsten Denkert, Stephen Charles Benz, Karsten E Weber, Patricia Spilman, Jan Budczies, Andreas Schneeweiß, Elmar Stickeler, Sabine Schmatloch, Christian Jackisch, Thomas Karn, Hans-Peter Sinn, Mathias Warm, Marion T van Mackelenbergh, Shahrooz Rabizadeh, Christian Schem, Ernst Heinmöller, Volkmar Mueller, Frederic Marmé, Patrick Soon-Shiong, Valentina Nekljudova, Michael Untch, Sibylle Loibl
Inferred immune-cell activity is an independent predictor of HER2 negative breast cancer prognosis and response to paclitaxel-based therapy in the GeparSepto trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Terence M Williams, Andreas Schneeweiß, Christian Jackisch, Changxian Shen, Karsten E Weber, Peter Andreas Fasching, Carsten Denkert, Jenny Furlanetto, Ernst Heinmöller, Sabine Schmatloch, Thomas Karn, Christopher W Szeto, Marion T van Mackelenbergh, Valentina Nekljudova, Elmar Stickeler, Patrick Soon-Shiong, Christian Schem, Thomas Mairinger, Volkmar Mueller, Frederic Marmé, Michael Untch, Sibylle Loibl
Caveolin gene expression predicts clinical outcomes for early-stage HER2-negative breast cancer treated with paclitaxel-based chemotherapy in the GeparSepto trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Anthony Cao, Jiaqing Yi, Xinyan Tang, Christopher W Szeto, Renyi Wu, Bing Wan, Xu Fang, Shou Li, Lei Wang, Lina Wang, Jing Li, Qiuping Ye, Tom Huang, Karl Hsu, Omar Kabbarah, Haiying Zhou
CD47-blocking Antibody ZL-1201 Promotes Tumor-associated Macrophage Phagocytic Activity and Enhances the Efficacy of the Therapeutic Antibodies and Chemotherapy. Cancer research communications 2 (11) (2022)
Anthony Cao, Jiaqing Yi, Xinyan Tang, Christopher W Szeto, Renyi Wu, Bing Wan, Xu Fang, Shou Li, Lei Wang, Lina Wang, Jing Li, Qiuping Ye, Tom Huang, Karl Hsu, Omar Kabbarah, Haiying Zhou
CD47-blocking Antibody ZL-1201 Promotes Tumor-associated Macrophage Phagocytic Activity and Enhances the Efficacy of the Therapeutic Antibodies and Chemotherapy. Cancer research communications 2 (11) (2022)
Mustafa I Jaber, Bing Song, Clive Taylor, Charles J Vaske, Stephen C Benz, Shahrooz Rabizadeh, Patrick Soon-Shiong, Christopher W Szeto
A deep learning image-based intrinsic molecular subtype classifier of breast tumors reveals tumor heterogeneity that may affect survival. Breast cancer research : BCR 22 (1) (2020)